Eli Lilly's Oncology Drug Is First Candidate For Australia's New Provisional Approval Pathway
Executive Summary
Australia gets the ball rolling on its new pathway for provisional approval of innovative prescription medicines.
You may also be interested in...
Merck Scores A First With Keytruda Under Australia's Provisional Pathway
The Therapeutic Goods Administration has provisionally approved new uses of the anticancer medicine based on early clinical data.
Increased Fees For Pharma Imminent In Australia
From July 1, pharmaceutical companies will pay higher fees to Australia’s Therapeutic Goods Administration.
Eligibility Decisions Near For Australia’s New Provisional Pathway
The first registration of a medicine under Australia’s new provisional approval pathway could take place at the end of this year, according to plans by the Therapeutic Goods Administration.